# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-11T14:37:27.554072
**Route:** OpenRouter + LaTeX
**Tokens:** 17744 in / 1427 out
**Response SHA256:** 09301f1b1e482e28

---

I reviewed the draft for fatal errors in the four mandated categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I checked every table and the key claims against the data and methods described.

Summary judgment: I found no fatal errors.

Notes (brief):
- Data-design alignment: Treatment years (treatment_year = effective_year + 1) are consistent with the stated data coverage (1999–2017). The latest treatment year is 2017 and the sample ends in 2017, and the text correctly notes that the 2017 cohort contributes only event time e = 0. The treatment timing in the adoption table matches descriptions in the text (e.g., NJ effective 2006 → treatment 2007; TN effective 2007 → treatment 2008). The paper documents use of not-yet-treated vs never-treated controls and is explicit about which is used where.
- Regression sanity: Reported coefficients and standard errors in all tables fall in plausible ranges for the outcome measures used (per-100,000 rates and log rates). I saw no SEs or coefficients that exceed the numeric thresholds specified in the checklist (no SE > 1000; no coefficient magnitudes > 100; no SE negative; no "NaN"/"NA"/"Inf" in reported results). Rounding and CIs are internally consistent with the reported SEs and p-values.
- Completeness: Regression tables report Observations, States, Treated States, and cluster-robust SEs; placebo and robustness tables are present. I did not find placeholder markers (NA / TBD / TODO / XXX) in tables or the main text. Figures and tables are all referenced and appear to have accompanying captions and notes. The adoption table lists sources for each state.
- Internal consistency: Numbers quoted in the text match table values (e.g.,overall CS-ATT = −0.014, SE = 0.293 in Table 1; event-study descriptions align with the figure captions and the discussion of cohort contributions). Treatment timing is used consistently (effective_year + 1) and the text repeatedly clarifies this choice and reports alternative coding in robustness checks.

Given the above, there are no fatal errors of the types you asked me to screen for. The paper can proceed to journal referee review.

ADVISOR VERDICT: PASS